Acadian Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Acadian Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,291	Closed	-$1.13M	–	2018
2025 Q4	$1.13M	Sell	5,291 -6,948	-57%	-$1.43M	﹤0.01%	1089
2025 Q3	$2.43M	Buy	+12,239	New	+$2.28M	﹤0.01%	846
2025 Q2	–	Sell	-411	Closed	-$64K	–	1653
2025 Q1	$64K	Sell	411 -71,648	-99%	-$10.2M	﹤0.01%	1405
2024 Q4	$9.91M	Sell	72,059 -48,835	-40%	-$6.42M	0.03%	360
2024 Q3	$18M	Sell	120,894 -21,271	-15%	-$2.87M	0.06%	247
2024 Q2	$19.4M	Sell	142,165 -108,327	-43%	-$14.7M	0.06%	243
2024 Q1	$37.8M	Buy	250,492 +234,446	+1,461%	+$33.5M	0.13%	149
2023 Q4	$2.02M	Buy	+16,046	New	+$1.6M	0.01%	667

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management's ASND Position: Q1 2026 in Review

Acadian Asset Management sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 5,291 shares — an estimated $1.13M sold.

Acadian Asset Management first reported a position in ASND in Q4 2023 and held it in 8 quarters. The position peaked at $37.8M in Q1 2024. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Acadian Asset Management reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
Acadian Asset Management sold 5,291 Ascendis Pharma A/S shares in Q1 2026, an estimated $1.13M.
Acadian Asset Management first reported a position in Ascendis Pharma A/S in Q4 2023 and held it in 8 quarters.
Acadian Asset Management's Ascendis Pharma A/S position peaked at $37.8M in Q1 2024.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.